The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
At least 13 people were killed in the storm, with searches underway for many more missing.
Children are risking their lives by taking part in a dangerous new social media craze called the paracetamol challenge, police have warned.
Obese mothers-to-be put their unborn child at risk of becoming overweight even while still in the womb, a senior children's doctor warns.